Blood Type Identification Reagent (Polyclonal)
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3822130000 | 10.0% | CN | US | 官方文档 |
| 3822190080 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
🩸 Blood Type Identification Reagent (Polyclonal)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand "Blood Grouping Reagents"?
Blood type identification reagents are critical diagnostic tools used in clinical laboratories and blood banks to determine a patient's blood group (ABO/Rh systems). These reagents typically consist of monoclonal or polyclonal antibodies that react specifically with red blood cell antigens.
In international trade, these are NOT classified as general chemicals or pharmaceuticals. They fall under a specialized category: Prepared Diagnostic or Laboratory Reagents.
⚠️ Key Distinction Point:
- If the reagent is specifically designed for Blood-Grouping → It falls under Heading 3822.13.00.00.
- If it is a diagnostic reagent for other purposes (e.g., hormone testing, glucose monitoring) → It falls under Heading 3822.19.00.80.
- Crucial Note: Reagents put up in kits or on backing must still adhere to this specificity. "Polyclonal" refers to the antibody source, but the application (blood grouping) dictates the classification.
📦 II. HS Code Classification Details (2026 Latest Tariff Authority Reference)
| HS Code | Product Description | Application Scenario | Blood-Grouping Specific? |
|---|---|---|---|
3822.13.00.00 |
Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits, other than those of heading 3006; certified reference materials: Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits: For blood-grouping | ABO/Rh typing kits, anti-A/anti-B sera, polyclonal antibodies for blood bank screening | ✅ YES (Specific to Blood Grouping) |
3822.19.00.80 |
Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits: Other Other: Other | Reagents for urine analysis, hormone testing, genetic testing, etc. | ❌ NO (Other diagnostic uses) |
🔍 Key Reminder:
- Since your product is "Blood Type Identification Reagent (Polyclonal)", it is explicitly used for blood-grouping.
- Therefore, it MUST be classified under3822.13.00.00.
- Do NOT misclassify it under3822.19.00.80("Other") unless the product is used for something else entirely. Misclassification can lead to customs delays or penalties.
💰 III. 2026 Latest Tariff Rate Breakdown (Including Surtaxes & Policy Additions)
✅ Applicable Country: United States (US)
✅ Country of Origin: China (CN)
✅ Effective Date: From November 10, 2025 (inclusive)
🎯 1. 3822.13.00.00 —— Diagnostic Reagents for Blood-Grouping
| Item | Content |
|---|---|
| Base Tariff | 0.0% (ad valorem) |
| Additional Surtax (Section 301/USITC) | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0% = $0 |
| De Minimis Exemption Eligibility | ✅ Yes (Subject to $800 de minimis threshold for low-value shipments) |
| Legal Basis Path | USITC:3822.13.00.00 → FOOTNOTE:3822.13.00.00 |
📌 Explanation:
- Base Rate: 0%. Diagnostic reagents, including those for blood grouping, generally benefit from low or zero base tariffs to encourage medical access.
- Additional Surtax: 0.0%. Unlike many electronics or steel products, diagnostic reagents are often exempt from the aggressive Section 301 retaliatory tariffs imposed on Chinese goods.
- Total Impact: Zero tariff burden. This is a highly favorable classification for cost control.
🎯 2. 3822.19.00.80 —— Other Diagnostic Reagents (For Comparison)
| Item | Content |
|---|---|
| Base Tariff | 0.0% |
| Additional Surtax | 0.0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0% = $0 |
📌 Note:
- Both blood-grouping and other diagnostic reagents currently carry 0% total tax.
- However, correct classification is vital for regulatory compliance (FDA requirements) and potential future policy changes.
🛠️ IV. Customs Clearance Operational Advice (Practical Pitfall Avoidance Guide)
✅ 1. Documentation Checklist (Mandatory)
| Document | Must Provide | Explanation |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must clearly state "For Blood-Grouping" or "ABO/Rh Typing". |
| ✅ Ingredient List | ✔️ | Specify "Polyclonal Antibodies" and target antigens (e.g., Anti-A, Anti-B). |
| ✅ Intended Use Statement | ✔️ | Explicitly declare: "Used in vitro for identification of human blood groups." |
| ✅ Commercial Invoice | ✔️ | Must use the exact HS Code 3822.13.00.00 and description matching USITC. |
| ✅ FDA Registration/Establishment ID | ✔️ | Reagents are regulated by FDA. Ensure prior registration is provided if required. |
| ✅ Certificate of Origin (CO) | ✔️ | To prove origin for potential future FTA benefits (though currently 0%). |
| ✅ Labeling Photos | ✔️ | Ensure labels comply with US labeling requirements for IVD devices. |
✅ 2. Declaration Tips (Key Mnemonic)
🔥 "Be Specific, Don't Broaden, Blood Grouping is Key!"
| Scenario | Correct Declaration | Wrong Practice |
|---|---|---|
| Reagents for ABO/Rh typing | 3822.13.00.00 "For blood-grouping" |
Misdeclaring as "General Chemicals" → 301%+ risk |
| Reagents for Urine Analysis | 3822.19.00.80 "Other" |
Misdeclaring as "Blood-grouping" → Incorrect compliance |
| Kits containing syringes + reagents | 3822.13.00.00 (if primarily reagents) |
Splitting declaration → Audit risk |
| Raw antibodies (unprepared) | Not 3822 (may be 3501/3502) | Misdeclaring as "Prepared Reagent" → Classification error |
✅ 3. Special Cases Handling
| Situation | Handling Advice |
|---|---|
| IVD Kits (In Vitro Diagnostic) | If the kit includes control sera and sample collection tubes, still classify under 3822.13.00.00 if the primary function is blood grouping. |
| Polyclonal vs. Monoclonal | The source (poly/mono) does not change the HS code; the application (blood grouping) does. Both go to 3822.13.00.00. |
| FDA Compliance | Even with 0% tariff, FDA may require prior notice or registration. Ensure all regulatory hurdles are cleared before shipment. |
| Cold Chain Shipping | Reagents often require refrigeration. Declare "Refrigerated Goods" to ensure proper handling by carriers. |
🌍 V. Global Market Clearance Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Certification Requirement | Notes |
|---|---|---|---|---|
| 🇺🇸 USA | 3822.13.00.00 |
0% | FDA Registration | Zero Tariff! High regulatory scrutiny but low tax. |
| 🇨🇳 China | 3822.13.00.00 |
~5-10% | NMPA Registration | Varies by import policy. |
| 🇪🇺 EU | 3822.00 |
0-4.5% | CE Marking + IVDR | Undergoing transition to IVDR regulations. |
| 🇬🇧 UK | 3822.00 |
0-4.5% | UKCA Marking | Post-Brexit rules apply. |
| 🇯🇵 Japan | 3822.00 |
0% | PMDA Approval | Generally zero tariff for medical diagnostics. |
📌 Conclusion:
- The USA is highly favorable for blood-type reagents with 0% tariff.
- The main challenge is regulatory compliance (FDA), not tariff costs.
- Ensure your product is properly registered with FDA before customs release.
📌 VI. Common Errors & Pitfall Guide (Lessons Learned)
❌ Error 1: Declaring as "General Chemicals" or "Biological Products"
👉 Consequence: Risk of misclassification audits, potential back-tariffs, and delays.
✅ Fix: Always use 3822.13.00.00 for blood-grouping reagents.
❌ Error 2: Omitting "For Blood-Grouping" in the declaration
👉 Consequence: Customs may classify under "Other" (3822.19.00.80) or require further inquiry, delaying clearance.
✅ Fix: Explicitly state the intended use in the commercial invoice.
❌ Error 3: Ignoring FDA Requirements
👉 Consequence: Goods held at port for FDA review, potential refusal of admission.
✅ Fix: Secure FDA establishment ID and prior notice before shipping.
❌ Error 4: Mislabeling Polyclonal vs. Monoclonal
👉 Consequence: Minor, but may trigger questions from regulatory bodies.
✅ Fix: Be accurate in technical specifications. Both are 0% tax, but accuracy builds trust.
🎯 VII. Conclusion: Precise Classification Saves Time & Ensures Compliance
🎯 Remember:
🔹 "Blood Grouping = 3822.13.00.00 = 0% Tariff!"
🔹 "Polyclonal or Monoclonal? Doesn't matter for Tariff, Only Application Matters."
🔹 "FDA First, Customs Second. Compliance is Key."
📌 Pro Tip:
If your reagents are shipped in small quantities (under $800), they may qualify for the de minimis exemption, allowing duty-free entry even if the base rate were higher (though here it's 0% anyway). Ensure your carrier utilizes this correctly.
📣 Immediate Action:
📞 Confirm FDA Registration Status +
📄 Prepare Detailed Specification Sheets +
🚀 Ship with 3822.13.00.00 for smooth, tariff-free clearance!
✨ Professional clearance starts with precise classification!
💼 Your diagnostics, globally accessible, tax-efficiently delivered!
用户评价
关于 HS 编码归类
协调制度（HS）是由世界海关组织（WCO）制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构：
- 章（2 位）——商品大类（例如：第 84 章：机器和机械设备）
- 品目（4 位）——章内的更具体分类
- 子目（6 位）——国际通用细分，所有 WCO 成员国统一使用
- 本国细分（8-10 位）——各国自行扩展的细分编码，如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时，适用的关税税率可能包括：
- 最惠国（MFN）税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税，如 301 条款（反倾销）、232 条款（国家安全）或反补贴税
本页内容仅供参考。如需正式归类，请咨询当地海关或持牌报关代理。